Lv4
620 积分 2023-07-17 加入
Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling
2个月前
已完结
Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
3个月前
已完结
Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B
3个月前
已完结
Regulation of type I interferon responses
3个月前
已完结
New Approaches to Chronic Hepatitis B
3个月前
已完结
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)
3个月前
已完结
慢性乙型肝炎防治指南
3个月前
已完结
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-Regression
3个月前
已完结
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
3个月前
已完结
New Perspectives on Development of Curative Strategies for Chronic Hepatitis B
3个月前
已完结
皖公网安备34019202002308
